News About: Pharm. Industry
Teams up for development of core pharmaceutical intermediates
Dasan Medicam, a local research-oriented pharmaceutical marker, is gearing up to take on Pfizer's Lipitor.
Targeting a bigger share in the domestic statin-based drugs market, Dasan has formed a strategic alliance w...
Doctors raked up 1.3 trillion won with bioequivalence-unproven drugs
With a total of 567 drugs whose bioequivalence testing has been unproven or falsified, doctors' claims for medical reimbursement has amounted to 1.3 trillion for the recent three years, according to data released by t...
Merck KGaA to invest 14 billion won in Korea
Merck KGaA, the world's leading supplier of liquid crystals, will invest 14 billion won to establish its advanced technology center in Korea on January 2008 as part of its plan to expand its position in the domestic l...
KPMA to support scientific events by third party
The Korea Pharmaceutical Manufacturers Association will sign a memorandum of understanding (MOU) with the Korean Institute of Medicine and the Korean Medical & Scientific Assistance Foundation on February 26 in a move...
FTC to look into drug makersKorea's antitrust regulator will re-embark on looking into the drug makers' undue business practices such as joint marketing.
The Fair Trade Commission (FTC) said on January ...
|
Domestic, foreign drug makers moving to join hands over low-priced drug incentive plan
Korean drug makers and multinationals will be likely to join hands to cope with the government's plan to pass a bill aiming at introducing the controversial incentive system for medical institution's low-priced drug p...
Daewoong hires ex-Amore Pacific research headDaewoong Pharm said it has recently hired former Amore Pacific research chief Kim Chung-joo as its laboratory head in charge of lifescience engineering.
A graduate of Seoul N...
|
New warning for Champix
The Korea Food and Drug Administration said it has called for increased awareness of the health risks of the smoking cessation drug Champix (varenicline).
To that end, the administration has requested Pfizer Korea,...
GSK margin policy under fire
The Pharmaceutical Development Consultative Committee has re-criticized the current wholesaler margin policy of GlaxoSmithKline.
In a morning gathering in February 11, the Committee Chairman Moon Jong-tae said that...
BMS Asia-Pacific Medical Chief namedBMS Korea said it has nominated Ahn Jong-ho, medical director, as its Asia-Pacific medical chief as of February 1.
Ahn, 44, will assume neurological affairs and multinational...
|
